Bausch Health Companies (BHC) Dividends payables (2009 - 2010)
Bausch Health Companies' (BHC) quarterly Dividends payables came in at $15.1 million in Q3 2010, up 5.88% year-on-year from $14.2 million in Q3 2009, and up 5.77% quarter-over-quarter from $14.3 million in Q2 2010.
Bausch Health Companies (BHC) Dividends payables (2009 - 2010) Analysis & Trends
Bausch Health Companies has disclosed Dividends payables across 2 years of filings, most recently posting $15.1 million for Q3 2010.
- Dividends payables for Q3 2010 came in at $15.1 million, up 5.88% year-over-year; the trailing twelve-month figure through Sep 2010 was $15.1 million (up 5.88% YoY), and the FY2009 annual result was $14.2 million, changed N/A from the prior year.
- Dividends payables came in at $15.1 million for Q3 2010 at Bausch Health Companies, up from $14.3 million in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $59.3 million in Q2 2009 to a low of $14.2 million in Q3 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 224.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 15.08 Mn |
| Jun 30, 2010 | 14.26 Mn |
| Dec 31, 2009 | 14.25 Mn |
| Sep 30, 2009 | 14.24 Mn |
| Jun 30, 2009 | 59.33 Mn |